Patient Guide: A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 96 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06389136
Status: 🟢 Enrolling Now
Condition: Atopic Dermatitis
Phase: PHASE3

Where You Can Participate

This study is available at 96 locations across the country.

Top locations include:
  • • Fayetteville, Arkansas
  • • Encino, California
  • • Mission Viejo, California
  • • And 93 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab - Join Clinical Trial NCTNCT06389136

How to Join This Clinical Trial - NCTNCT06389136

Learn how to participate in this PHASE3 trial studying an investigational therapy for Atopic Dermatitis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Atopic Dermatitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Atopic Dermatitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06389136 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 96 locations. Find a study site near you:

Clinical Research Site

Fayetteville, Arkansas 72703 - United States

Status: RECRUITING

Clinical Research Site

Encino, California 91436 - United States

Status: RECRUITING

Clinical Research Site

Mission Viejo, California 92691 - United States

Status: RECRUITING

Clinical Research Site

Oceanside, California 92056 - United States

Status: RECRUITING

Clinical Research Site

Redwood City, California 94063 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95815 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 92121 - United States

Status: RECRUITING

Clinical Research Site

Thousand Oaks, California 91320 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: RECRUITING

Clinical Research Site

Boca Raton, Florida 33428 - United States

Status: COMPLETED

And 86 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Atopic Dermatitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships